I've reviewed the presentation data. Looks reasonable to me. Nothing glamorous. The wow factor really is how simple ( if not boring) the strategy appears to be articulated. I'd much rather that than some wishful thinking trash some of the other penny dreadfuls put out. For management to be pulled from all over the shop and then in 6 months come up with a stabilise and reset plan, then to have a vision with defined steps in place is not too bad. My only concern is the acid test metric this half is under more pressure compared to pcp. Hoping the cash they are directing to bolster there ANZ sales can have a quick impact by way of increased cashflow.
ISD Price at posting:
27.5¢ Sentiment: Hold Disclosure: Held
